Clinical Trial Update: Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated postprandial administration of a faster-acting insulin analogue versus pre-prandial administration of an acting-insulin analogue in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis-related Diabetes

Drugs mentioned

• Acting-insulin analogue
• Faster-acting insulin analogue

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Cystic Fibrosis-related Diabetes | Phase 4 | Status: TERMINATED